Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Severe Gut Acute Graft Versus host Disease (GVHD) Influence Thrombotic Microangiopathy in 86 Allogeneic Hematopoietic Stem Cell Recipients Who Received Tacrolimus-Based Regimen for GVHD Prophylaxis

Jorge Labrador, MD, Oriana López-Godino, Lucía López-Corral, MD, Estefanía Pérez-López, MD, Mónica Cabrero-Calvo, MD, Roberto Pérez-López, José María Bastida, Miriam López-Parra, Ignacio Alberca, PhD, José Ramón González-Porras, PhD, Dolores Caballero, MD

Blood (2012) 120 (21): 1955.

https://doi.org/10.1182/blood.V120.21.1955.1955

Published: 2012

Journal Articles

Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis

Javier Corral, David Hernandez-Espinosa, Jose Manual Soria, Rocio Gonzalez-Conejero, Adriana Ordonez, Jose Ramon Gonzalez-Porras, Elena Perez-Ceballos, Ramon Lecumberri, Ignacio Sanchez, Vanessa Roldan, Jose Mateo, Antonia Minano, Marcos Gonzalez, Ignacio Alberca, Jordi Fontcuberta, Vicente Vicente

Blood (2007) 109 (10): 4258–4263.

https://doi.org/10.1182/blood-2006-08-040774

Published: 2007

Journal Articles

Study on the Efficacy and Safety of IGIV3I Grifols (Human Intravenous Immunoglobulin) in Patients Diagnosed with Chronic Immune Thrombocytopenic Purpura.

Antonio Julia, MD, PhD, Lidia Kovaleva, MD, PhD, Ignacio Alberca, MD, PhD, Fernando Hernandez, MD, PhD, Svetlana Loria, MD, PhD, Virgilio Sandoval, MD, PhD, Antonio Vidaller, MD, PhD, Jorge Sierra, MD, PhD

Blood (2006) 108 (11): 3956.

https://doi.org/10.1182/blood.V108.11.3956.3956

Published: 2006

Journal Articles

A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosis

Javier Corral, Rocio González-Conejero, Jose Manuel Soria, Jose Ramón González-Porras, Elena Pérez-Ceballos, Ramón Lecumberri, Vanessa Roldán, Juan Carlos Souto, Antonia Miñano, David Hernández-Espinosa, Ignacio Alberca, Jordi Fontcuberta, Vicente Vicente

Blood (2006) 108 (1): 177–183.

https://doi.org/10.1182/blood-2005-08-3249

Published: 2006

Journal Articles

Leu208Val and Ile181Leu variants of cytochrome P450 CYP2C9 are not related to the acenocoumarol dose requirement in a Spanish population

José Zarza, José Hermida, Ramón Montes, Ignacio Alberca, Marı́a Luz López, Eduardo Rocha

Blood (2002) 100 (2): 734–735.

https://doi.org/10.1182/blood-2002-03-0821

Published: 2002

Journal Articles

Differential effects of 2C93 and 2C92 variants of cytochrome P-450 CYP2C9 on sensitivity to acenocoumarol

José Hermida, José Zarza, Ignacio Alberca, Ramón Montes, Marı́a Luz López, Eva Molina, Eduardo Rocha

Blood (2002) 99 (11): 4237–4239.

https://doi.org/10.1182/blood.V99.11.4237

Published: 2002

NARROW

Severe Gut Acute Graft Versus host Disease (GVHD) Influence Thrombotic Microangiopathy in 86 Allogeneic Hematopoietic Stem Cell Recipients Who Received Tacrolimus-Based Regimen for GVHD Prophylaxis

Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis

Study on the Efficacy and Safety of IGIV3I Grifols (Human Intravenous Immunoglobulin) in Patients Diagnosed with Chronic Immune Thrombocytopenic Purpura.

A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosis

Leu208Val and Ile181Leu variants of cytochrome P450 CYP2C9 are not related to the acenocoumarol dose requirement in a Spanish population

Differential effects of 2C93 and 2C92 variants of cytochrome P-450 CYP2C9 on sensitivity to acenocoumarol

Email alerts

ASH Publications

American Society of Hematology

Severe Gut Acute Graft Versus host Disease (GVHD) Influence Thrombotic Microangiopathy in 86 Allogeneic Hematopoietic Stem Cell Recipients Who Received Tacrolimus-Based Regimen for GVHD Prophylaxis

Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis

Study on the Efficacy and Safety of IGIV3I Grifols (Human Intravenous Immunoglobulin) in Patients Diagnosed with Chronic Immune Thrombocytopenic Purpura.

A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosis

Leu208Val and Ile181Leu variants of cytochrome P450 CYP2C9 are not related to the acenocoumarol dose requirement in a Spanish population

Differential effects of 2C9*3 and 2C9*2 variants of cytochrome P-450 CYP2C9 on sensitivity to acenocoumarol

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only

Differential effects of 2C93 and 2C92 variants of cytochrome P-450 CYP2C9 on sensitivity to acenocoumarol